Barclays raised the firm’s price target on Fresenius Medical (FMS) to EUR 39 from EUR 38.50 and keeps an Equal Weight rating on the shares.
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Fresenius Medical price target raised to EUR 37.30 from EUR 35.40 at JPMorgan
- Fresenius Medical ADRs initiated with a Buy at Berenberg
- Fresenius Medical Care Reports Strong Q3 2024 Results
- Fresenius Medical Care Unveils New Long-Term Incentive Plan
- Fresenius Medical reports Q3 EPS EUR0.73 vs. EUR0.29 last year